161 tracked 13F filers disclose a position in CRVS as of the latest SEC 13F filings, a combined $1.0B in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | ORBIMED ADVISORS LLC | $104.8M | 7.2M | —Held | Q1 2026 | |
| 2 | BlackRock, Inc. | $90.1M | 6.2M | ▲+22% Added · +1.1M sh | Q1 2026 | |
| 3 | STATE STREET CORP | $66.8M | 4.5M | ▲+25% Added · +908K sh | Q2 2026 | |
| 4 | ADAMS STREET PARTNERS LLC | $48.9M | 3.3M | —Held | Q2 2026 | |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | $47.3M | 3.2M | →First observed position No prior filed position | Q1 2026 | |
| 6 | PRICE T ROWE ASSOCIATES INC /MD/ | $42.7M | 2.9M | ▲86× Added · +2.9M sh | Q1 2026 | |
| 7 | Vivo Capital, LLC | $41.9M | 2.8M | —Held | Q2 2026 | |
| 8 | MORGAN STANLEY | $36.6M | 2.5M | ▼−30% Reduced · −1.1M sh | Q1 2026 | |
| 9 | Deep Track Capital, LP | $36.5M | 2.5M | ▲New +2.5M sh | Q1 2026 | |
| 10 | PERCEPTIVE ADVISORS LLC | $33.5M | 2.3M | ▲+231% Added · +1.6M sh | Q1 2026 | |
| 11 | Commodore Capital LP | $33.0M | 2.3M | ▲New +2.3M sh | Q1 2026 | |
| 12 | BRAIDWELL LP | $31.8M | 2.1M | ▲+21% Added · +374K sh | Q2 2026 | |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | $27.7M | 1.9M | ▲+8.2% Added · +141K sh | Q2 2026 | |
| 14 | Foresite Capital Management VI LLC | $26.8M | 1.8M | ▲+33% Added · +450K sh | Q1 2026 | |
| 15 | MPM BioImpact LLC | $24.5M | 1.7M | ▼−39% Reduced · −1.1M sh | Q1 2026 | |
| 16 | Hood River Capital Management LLC | $23.5M | 1.6M | ▲+18% Added · +237K sh | Q2 2026 | |
| 17 | GOLDMAN SACHS GROUP INC | $22.5M | 1.5M | ▲+178% Added · +987K sh | Q1 2026 | |
| 18 | Boxer Capital Management, LLC | $16.1M | 1.1M | ▲New +1.1M sh | Q1 2026 | |
| 19 | Catalio Capital Management, LP | $16.1M | 1.1M | ▲+21% Added · +189K sh | Q2 2026 | |
| 20 | MILLENNIUM MANAGEMENT LLC | $12.7M | 866K | ▲+26% Added · +178K sh | Q1 2026 | |
| 21 | ADAGE CAPITAL PARTNERS GP, L.L.C. | $11.0M | 750K | ▲New +750K sh | Q1 2026 | |
| 22 | Eversept Partners, LP | $11.2M | 748K | ▲New +748K sh | Q2 2026 | |
| 23 | EMERALD ADVISERS, LLC | $10.2M | 686K | ▼−0.1% Reduced · −533 sh | Q2 2026 | |
| 24 | VANGUARD PORTFOLIO MANAGEMENT LLC | $9.8M | 670K | →First observed position No prior filed position | Q1 2026 | |
| 25 | Blue Owl Capital Holdings LP | $9.1M | 609K | ▲+12% Added · +64K sh | Q2 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 25 funds opened a new position in CRVS and 23 added to an existing one, while 11 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| ELI LILLY & COLLY | 78 funds | $44.3B |
| NVIDIA CORPNVDA | 75 funds | $226.2B |
| AMAZON.COM INCAMZN | 74 funds | $109.7B |
| BROADCOM INCAVGO | 73 funds | $90.9B |
| MICRON TECHNOLOGY INCMU | 73 funds | $18.7B |
| LAM RESEARCH CORPLRCX | 72 funds | $18.3B |
| MICROSOFT CORPMSFT | 70 funds | $155.9B |
| ALPHABET INC-CL AGOOGL | 70 funds | $90.3B |
| ADVANCED MICRO DEVICESAMD | 70 funds | $20.1B |
| COSTCO WHOLESALE CORPCOST | 70 funds | $19.3B |
| META PLATFORMS INC-CLASS AMETA | 69 funds | $64.4B |
| VISA INC-CLASS A SHARESV | 69 funds | $38.0B |
Ranked by how many of CRVS's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jun 11, 2026 | Moore David Scott | Director | Buy (P) | 22K | $250K |
| May 18, 2026 | MILLER RICHARD A MD | President and CEO, Director | Buy (P) | 5K | $60K |
| May 18, 2026 | MILLER RICHARD A MD | President and CEO, Director | Buy (P) | 2K | $23K |
| Jun 27, 2025 | Thompson Peter A. | Director, 10% Owner | Sell (S) | 1.2M | $4.9M |
| Jun 27, 2025 | ORBIMED ADVISORS LLC | Director, 10% Owner | Sell (S) | 1.2M | $4.9M |
| May 6, 2024 | MILLER RICHARD A MD | President and CEO, Director | Buy (P) | 578K | $999K |
| May 6, 2024 | Jones William Benton | See Remarks | Buy (P) | 20K | $35K |
| May 15, 2023 | Grais Linda | Director | Buy (P) | 10K | $25K |
| Dec 20, 2022 | Jones William Benton | See Remarks | Buy (P) | 20K | $16K |
| Dec 14, 2022 | MILLER RICHARD A MD | President and CEO, Director | Buy (P) | 10K | $8K |
| Dec 14, 2022 | LEA LEIV | Chief Financial Officer | Buy (P) | 4K | $3K |
| Dec 13, 2022 | MILLER RICHARD A MD | President and CEO, Director | Buy (P) | 50K | $37K |
Connected entities for CRVS
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/CRVS/capital-change-brief"
Use Arkolith's capital_change_brief for CRVS. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for CRVS. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.